Shoushtari, A. N., Friedman, C. F., Navid-Azarbaijani, P., Postow, M. A., Callahan, M. K., Momtaz, P., . . . Chapman, P. B. (2018). Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma. JAMA oncology, 4(1), 98. https://doi.org/10.1001/jamaoncol.2017.2391
Chicago Style (17th ed.) CitationShoushtari, Alexander N., Claire F. Friedman, Pedram Navid-Azarbaijani, Michael A. Postow, Margaret K. Callahan, Parisa Momtaz, Katherine S. Panageas, Jedd D. Wolchok, and Paul B. Chapman. "Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma." JAMA Oncology 4, no. 1 (2018): 98. https://doi.org/10.1001/jamaoncol.2017.2391.
MLA (9th ed.) CitationShoushtari, Alexander N., et al. "Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma." JAMA Oncology, vol. 4, no. 1, 2018, p. 98, https://doi.org/10.1001/jamaoncol.2017.2391.